Evofem Biosciences, Inc. Quarterly Return On Assets in % from Q3 2015 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Evofem Biosciences, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2015 to Q3 2024.
  • Evofem Biosciences, Inc. Return On Assets for the quarter ending September 30, 2024 was -61.9 %, a 126% decline year-over-year.
  • Evofem Biosciences, Inc. annual Return On Assets for 2023 was 331 %.
  • Evofem Biosciences, Inc. annual Return On Assets for 2022 was -197 %, a 25% increase from 2021.
  • Evofem Biosciences, Inc. annual Return On Assets for 2021 was -263 %, a 72.3% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -61.9 -300 -126% Jul 1, 2024 Sep 30, 2024
Q2 2024 595 +333 +128% Apr 1, 2024 Jun 30, 2024
Q1 2024 438 +566 Jan 1, 2024 Mar 31, 2024
Q4 2023 331 +529 Oct 1, 2023 Dec 31, 2023
Q3 2023 238 +515 Jul 1, 2023 Sep 30, 2023
Q2 2023 261 +834 Apr 1, 2023 Jun 30, 2023
Q1 2023 -128 +173 +57.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 -197 +65.6 +25% Oct 1, 2022 Dec 31, 2022
Q3 2022 -278 -72.9 -35.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -573 -431 -305% Apr 1, 2022 Jun 30, 2022
Q1 2022 -302 -151 -101% Jan 1, 2022 Mar 31, 2022
Q4 2021 -263 -110 -72.3% Oct 1, 2021 Dec 31, 2021
Q3 2021 -205 -47.6 -30.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 -141 +39 +21.6% Apr 1, 2021 Jun 30, 2021
Q1 2021 -150 +86 +36.4% Jan 1, 2021 Mar 31, 2021
Q4 2020 -153 +104 +40.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 -157 +170 +52% Jul 1, 2020 Sep 30, 2020
Q2 2020 -180 +273 +60.2% Apr 1, 2020 Jun 30, 2020
Q1 2020 -236 +381 +61.7% Jan 1, 2020 Mar 31, 2020
Q4 2019 -256 +672 +72.4% Oct 1, 2019 Dec 31, 2019
Q3 2019 -327 +635 +66% Jul 1, 2019 Sep 30, 2019
Q2 2019 -453 +1.19K +72.3% Apr 1, 2019 Jun 30, 2019
Q1 2019 -617 +1.85K +75% Jan 1, 2019 Mar 31, 2019
Q4 2018 -928 +517 +35.8% Oct 1, 2018 Dec 31, 2018
Q3 2018 -962 +49.3 +4.88% Jul 1, 2018 Sep 30, 2018
Q2 2018 -1.64K -1.15K -234% Apr 1, 2018 Jun 30, 2018
Q1 2018 -2.47K -2.09K -549% Jan 1, 2018 Mar 31, 2018
Q4 2017 -1.45K -1.1K -314% Oct 1, 2017 Dec 31, 2017
Q3 2017 -1.01K -767 -315% Jul 1, 2017 Sep 30, 2017
Q2 2017 -490 -357 -268% Apr 1, 2017 Jun 30, 2017
Q1 2017 -381 -272 -251% Jan 1, 2017 Mar 31, 2017
Q4 2016 -349 -274 -363% Oct 1, 2016 Dec 31, 2016
Q3 2016 -244 -189 -344% Jul 1, 2016 Sep 30, 2016
Q2 2016 -133 Apr 1, 2016 Jun 30, 2016
Q1 2016 -108 Jan 1, 2016 Mar 31, 2016
Q4 2015 -75.4 Oct 1, 2015 Dec 31, 2015
Q3 2015 -55 Jul 1, 2015 Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.